Hyperglycemic conditions modulate connective tissue reorganization by human vascular smooth muscle cells through stimulation of hyaluronan synthesis

Glycobiology

Volumn 20, Issue 9, 2010, Pages 1117-1126

  Sainio, Annele ^a   Jokela, Tiina ^b   Tammi, Markku I ^b   Järveläinen, Hannu ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

hyaluronan; hyperglycemic conditions; matrix remodeling; vascular cells

Indexed keywords

COLLAGEN GEL; COLLAGEN TYPE 1; ENZYME; GLUCOSE; HYALURONIC ACID; HYALURONIC ACID SYNTHASE 1; HYALURONIC ACID SYNTHASE 2; HYALURONIC ACID SYNTHASE 3; HYALURONIDASE; HYMECROMONE; UNCLASSIFIED DRUG;

ARTICLE; CONNECTIVE TISSUE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MICROARRAY ANALYSIS; MUSCLE CONTRACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

CELLS, CULTURED; CONNECTIVE TISSUE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GLUCOSE; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; HYMECROMONE; HYPERGLYCEMIA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE;

EID: 77955439924     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwq076     Document Type: Article

References (62)

1. Air EL, Kissela BM. 2007. Diabetes, the metabolic syndrome and ischemic stroke: epidemiology and possible mechanisms. Diabetes Care. 30: 3131-3140.
2. Bobbink IW, de Boer HC, Tekelenburg WL, Banga JD, de Groot PG. 1997. Effect of extracellular matrix glycation on endothelial cell adhesion and spreading: involvement of vitronectin. Diabetes. 46:87-93.
3. Brownlee M. 2001. Biochemistry and molecular biology of diabetic complications. Nature. 414:813-820.
4. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Giugkiano D. 2008. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 57:1349-1354.
5. Chung IM, Gold HK, Schwartz SM, Ikari Y, Reidy MA, Wight TN. 2002. Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol. 40:2072-2081.
6. Corpus RA, George PB, House JA, Dixon SR, Ajluni SC, Devlin WH, Timmis GC, Balasubramaniam M, O'Neill WW. 2004. Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol. 43:8-14.
7. DECODE Study Group. 2001. The European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 161:397-405.
8. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, MazzoneT, Raskin P. 2008. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 117:1610-1619.
9. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Dennis Lempicki RA. 2003. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4:P3.
10. de La Motte CA, Hascall VC, Calabro A, Yen-Lieberman B, Strong SA. 1999. Mononuclear leucocytes preferentially bind via CD44 to hyaluronan on human intestinal mucosal smooth muscle cells after virus infection on treatment with poly(I.C.). J Biol Chem. 274:30747-30755.
11. Erikstrup C, Pedersen L-M, Heickendorff L, Ledet T, Rasmussen LM. 2001. Production of hyaluronan and chondroitin sulphate proteoglycans from human arterial smooth muscle\the effect of glucose, insulin, IGF-I or growth hormone. Eur J Endocrinology. 145:193-198.
12. Evanko SP, Angello JC, Wight TN. 1999. Formation of hyaluronan-and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 19:1004-1013.
13. Evanko SP, Johnson PY, Braun KR, Underhill CB, Dudhia J, Wight TN. 2001. Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells. Arch Biochem Biophys. 394:29-38.
14. Evanko SP, Tammi MI, Tammi RH, Wight TN. 2007. Hyaluronan-dependent pericellular matrix. Adv Drug Deliv Rev. 59:1351-1365.
15. Farb A, Kolodgie FD, Hwang J-Y, Burke AP, Tefera K, Weber DK, Wight TN, Virmani R. 2004. Extracellular matrix changes in stented human coronary arteries. Circulation. 110:940-947.
16. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. 1983. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J. 287:867-870.
17. Glisin V, Crkvenjakov R, Byus C. 1974. Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry. 13:2633-2637.
18. Heickendorff L, Ledet T, Rasmussen LM. 1994. Glycosaminoglycans in the human aorta in diabetes mellitus: a study of tunica media from areas with and without atherosclerotic plaque. Diabetologia. 37:286-292.
19. Hiltunen EL, Anttila M, Kultti A, Ropponen K, Penttinen J, Yliskoski M, Kuronen AT, Juhola M, Tammi R, Tammi M, et al. 2002. Elevated hya-luronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors. Cancer Res. 15:6410-6413.
20. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 2008. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 359:1565-1576.
21. Ihalainen S, Soliymani R, Iivanainen E, Mykkänen K, Sainio A, Pöyhönen M, Elenius K, Järveläinen H, Viitanen M, Kalimo H, et al. 2007. Proteome analysis of cultivated vascular smooth muscle cells from a CADASIL patient. Mol Med. 13:305-314.
22. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, Shinomura T, Hamaguchi M, Yoshida Y, Ohnuki Y, et al. 1999. Three isoforms of mammalian hyaluronan syhthases have distinct enzymatic properties. J Biol Chem. 274:25085-25092.
23. Jacobson A, Brinck J, Briskin MJ, Spicer AP, Heldin P. 2000. Expression of human hyaluronan synthases in response to external stimuli. Biochem J. 348:29-35.
24. Järveläinen H, Pelliniemi TT, Rönnemaa T. 1985. The stabilizing effect of glu-cocorticoids on human endothelial cells in culture. Scand J Clin Lab Invest. 45:223-228.
25. Järveläinen H, Rönnemaa T, Viikari J. 1986. Effect of sera from male type 2 (non-insulin-dependent) diabetics on human aortic smooth muscle cells in culture. Med Biol. 64:361-366.
26. Järveläinen H, Rönnemaa T, Lehtonen A. 1987. Effect of sera from male type I (insulin-dependent) diabetics on human aortic smooth muscle cells in culture. Acta Endocrinol (Copenhagen). 114:362-370.
27. Järveläinen H, Vernon RB, Gooden MD, Francki A, Lara S, Johnson PY, Kinsella MG, Sage EH, Wight TN. 2004. Overexpression of decorin by rat arterial smooth muscle cells enhances contraction of type I collagen in vitro. Arterioscler Thromb Vasc Biol. 24:67-72.
28. Karvinen S, Pasonen-Seppänen S, Hyttinen JM, Pienimäki JP, Törrönen K, Jokela TA, Tammi MI, Tammi R. 2003. Keratinocyte growth factor stimulates migration and hyaluronan synthesis in the epidermis by activation of keratinocyte hyaluronan synthases 2 and 3. J Biol Chem. 278: 49495-49504.
29. Kolodgie FD, Burke AP, Farb A, Weber DK, Kutys R, Wight TN, Virmani R. 2002. Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arterioscler Thromb Vasc Biol. 22:1642-1648.
30. Kornowski R, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA, Honq MK, Popma JJ, Leon MB. 1997. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyper-plasia. A serial intravascular ultrasound study. Circulation. 95:1366-1369.
31. Koshiishi I, Shizari M, Underhill CB. 1994. CD44 can mediate the adhesion of platelets to hyaluronan. Blood. 84:390-396.
32. Kultti A, Pasonen-Seppänen S, Jauhiainen M, Rilla KJ, Kärnä R, Pyöriä E, Tammi RH, Tammi MI. 2009. 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3. Exp Cell Res. 315:1914-1923.
33. Kultti A, Rilla K, Tiihonen R, Spicer AP, Tammi RH, Tammi MI. 2006. Hya-luronan synthesis induces microvillus-like cell surface protrusions. J Biol Chem. 281:15821-15828.
34. Marso SP, Hiatt WR. 2006. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol. 47:921-929.
35. McDonald TO, Gerrity RG, Jen C, Chen H-J, Wark K, Wight TN, Chait A, O'Brien KD. 2007. Diabetes and arterial extracellular matrix changes in a porcine model of atherosclerosis. J Histochem Cytochem. 55:1149-1157.
36. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B. 2005. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 353:2643-2653.
37. Ngo P, Ramalingam P, Phillips JA, Furuta GT. 2006. Collagen gel contraction assay. Methods Mol Biol. 341:103-109.
38. Nieuwdorp M, Holleman F, de Groot E, Vink H, Gort J, Kontush A, Chapman MJ, Hutten BA, Brouwer CB, Hoekstra JBL, et al. 2007. Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis. Diabetologia. 50:1288-1293.
39. Norhammer A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K. 2002. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 359:2140-2144.
40. Raines EW. 2000. The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationship to vascular disease. Int J Exp Path. 81:173-182.
41. R Development Core Team. 2006. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, ISBN 3-900051-07-0, URL http://www.R-project.org.
42. Riessen R, Wight TN, Pastore C, Henley C, Isner JM. 1996. Distribution of hyaluronan during extracellular matrix remodelling in human restenotic arteries and ballon-injured rat carotid arteries. Circulation. 93:1141-1147.
43. Saavalainen K, Tammi MI, Bowen T, Schmitz ML, Carlberg C. 2007. Integration of the activation of the human hyaluronan synthase 2 gene promoter by common cofactors of the transcription factors retinoic acid receptor and nuclear factor kappaB. J Biol Chem. 282:11530-11539.
44. Spijkerman AM, Dekker JM, Nijpels G, Jager A, Kostense PJ, van Hinsbergh VW, Bouter LM, Heine RJ, Stehouwer CD. 2002. Impact of diabetes duration and cardiovascular risk factors on mortality in type 2 diabetes: the Hoorn study. Eur J Clin Invest. 32:924-930.
45. Sussmann M, Sarbia M, Meyer-Kirchrath J, Nüsing RM, Schrör K, Fischer JW. 2004. Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins. Circ Res. 94:592-600.
46. Tabas I, Williams KJ, Boren J. 2007. Subendothelial lipoprotein retention as the initiating process in atherosclerosis. Update and therapeutic implications. Circulation. 116:1832-1844.
47. Takeda M, Babazono T, Nitta K, Iwamoto Y. 2001. High glucose stimulates hya-luronan production by renal interstitial fibroblasts through the protein kinase C and transforming growth factor-β cascade. Metabolism. 50:789-794.
48. Toole BP, Wight TN, Tammi MI. 2002. Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem. 277:4593-4596.
49. Toutouzas K, Colombo A, Stefanadis C. 2004. Inflammation and restenosis after percutaneous coronary interventions. Eur Heart J. 25:1679-1687.
50. Van den Boom M, Sarbia M, von Wnuck Lipinski K, Mann P, Meyer-Kirchrath J, Rauch BH, Grabitz K, Levkau B, Schrör K, Fischer JW. 2006. Differential regulation of hyaluronic acid synthase isoforms in human saphenous vein smooth muscle cells: possible implications for vein graft stenosis. Circ Res. 98:36-44.
51. Velander P, Theopol C, Hirsch T, Bleiziffer O, Zuhaili B, Fossum M, Hoeller D, Gheerardyn R, Chen M,Visovatti S, et al. 2008. Impaired wound healing in an acute pig model and the effects of local hyperglycemia. Wound Rep Reg. 16:288-293.
52. Vigetti D, Rizzi M, Viola M, Karousou E, Genasett A, Clerici M, Bartolini B, Hascall VC, DeLucaG, PassiA. 2009. The effectas of 4-methylumbelliferone on hyaluronan synthesis, MMP activity, proliferation, and motility of human aortic smooth muscle cells. Glycobiology. 19:537-546.
53. Vigetti D, Viola M, Karousou E, Rizzi M, Moretto P, Genasetti A, Clerici M, Hascall VC, De Luca G, Passi A. 2008. Hyaluronan-CD44-ERK1/2 regulate human aortic smooth muscle cell motility during aging. J Biol Chem. 283:4448-4458.
54. Wang A, Hascall VC. 2004. Hyaluronan structures synthesized by rat mesan-gial cells in reponse to hyperglycemia induce monocyte adhesion. J Biol Chem. 279:10279-10285.
55. Wasty F, Alavi MZ, Moore S. 1993. Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus. Diabetologia. 36:316-322.
56. Weigel PH, DeAngelis PL. 2007. Hyaluronan synthases: a decade-plus of novel glycosyltransferases. J Biol Chem. 282:36777-36781.
57. West NE, Ruygrok PN, Disco CM, Webster MW, Lindeboom WK, O'Neill WW, Mercado NF, Serruys PW. 2004. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients. Circulation. 109:867-873.
58. Wight TN. 1996. Vascular extracellular matrix. In: Fuster V, Ross R and Topol EJ, editors. Atherosclerosis and Coronary Heart Disease. New York: Raven Press, 421-440.
59. Wight TN, Merrilees MJ. 2004. Proteoglycans in atherosclerosis and resteno-sis: key roles for versican. Circ Res. 94:1158-1167.
60. Williams KJ, Tabas I. 1995. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 15:551-561.
61. Wilson PW. 2001. Diabetes mellitus and coronary heart disease. Endocrinol Metab Clin North Am. 30:857-881.
62. Yevdokimova NY. 2006. Elevated level of ambient glucose stimulates the synthesis of high-molecular-weight hyaluronic acid by human mesangial cells. The involvement of transforming growth factor beta1 and its activation by thrombospondin-1. Acta Biochim Pol. 53:383-393.